dockets: FDA-2005-P-0313

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id
FDA-2005-P-0313 FDA FDA to Refuse to Approve ANDA or Section 505(b)(2), for Inhalation Drug Products Containing A Combination of the Active Ingredients Albuterol Sulfate & Ipratropium Hydrochloirde Administered by Nebulization for the Treatment of Chronic Pulmonary Obstructive Disorder-CLOSED Nonrulemaking 2021-09-01T01:01:24Z 0b000064804479c2

Links from other tables